NVS

Novartis AG

HealthcareDrug Manufacturers - GeneralCHUSDPeers →Country macro →

$147.08

-1.88%LiveJun 18, 2026

AI Brief

Market cap

$280.64B

52w range

112.34 – 170.46

P / E

—

EPS

—

Volume

1.67M

Revenue · FY

—

Overview Fundamentals Market Narrative & AI

Explain this page

Arphra AIPlain-English read on Novartis AG’s valuation

Consensus target

$141.00-4.1%

$112$170

Low $112Median $141High $170

Rating distribution

No rating distribution on file.

Composite rating

B+

Score 3/5

Consensus

—

Target consensus

$141.00

-4.13% vs spot

Recent activity

1 ratings

Last 30 days

Ratings snapshot

DB · ratings_historyJun 08, 2026

Composite

B+

3/5 score

Components (1-5)

Discounted CF
4
Return on equity
5
Return on assets
5
Debt / equity
1
Price / earnings
2
Price / book
1

No grades consensus available.

Price target · summary

DB · price_targets_historyJun 08, 2026

Last month

$141.00

1 snapshots-4.13%

Last quarter

$141.00

1 snapshots-4.13%

Last year

$141.00

1 snapshots-4.13%

All-time

$141.00

1 snapshots-4.13%

Low

$112.00

-23.85% vs spot

Median

$141.00

-4.13% vs spot

High

$170.00

+15.58% vs spot

Estimate revisions · forward years

Sell-side consensus EPS / Revenue / EBITDA over time, per forward fiscal year.

2026-12-31

1 snapshots

EPS—

Revenue ($B)—

2027-12-31

1 snapshots

EPS—

Revenue ($B)—

2028-12-31

1 snapshots

EPS—

Revenue ($B)—

Peer comparables

Green = best, red = worst (per column)

Ticker	Mcap	P/E	P/S	EV/EBITDA	ROE	D/E	Div Yield
NVSNovartis AGFocus	279.92B	—	—	14.4×	—	—	—

Analyst grade actions — 5 years

Stacked monthly counts

No analyst-grade actions in analyst_grades for NVS over the last 5 years.

Historical ratings

DB · ratings_history1

Date	Composite	Score	DCF	ROE	ROA	D/E	P/E	P/B
Jun 08, 2026	B+	3	4	5	5	1	2	1